Molecular Diagnostics, the IVD industry’ segment, refers to the tests measuring DNA and RNA, as well as various products of metabolism to discover mutations, specific genotypes or any biochemical alterations which may be linked to certain health states or disease conditions. This science owns its emergence to the advancements in biology that have deepened the knowledge of the mechanisms of molecular-level processes, both normal and malignant.
Molecular Diagnostics is by far the most hastily progressing sector. The oncoming decade will be ear-marked by far-reaching advances in reagent and automation systems, along with the advent of a generous assortment of novelties set to inevitably call for innovative marketing techniques. The percentage of market penetration into day-to-day habitual clinical lab settings, though, will revolve around the arrival of money’s worth and automatized systems with amplification techniques. Some of the firms reigning over the market are Abbott Diagnostics, Celera, Sysmex Corporation, Roche Diagnostics, Qiagen N.V., Siemens Medical Solutions Diagnostics, and more.
The research reports from this Catalogue look at the Molecular Diagnostics Market on every imaginable geography level, covering key technology and medical trends. The issues mentioned in the research reports are varied, ranging from market sizing, share and segmentation to new product introductions and regulatory landscape. Further, the research reports highlight market penetration strategies, potential enter barriers, competitive profiles, besides offering the Molecular Diagnostics Market forecasts.
Publications found:
652
Sort by:
Global Molecular Diagnostic Analyzers and Reagents, 2019-2023: USA, Europe, Japan-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing-Supplier Shares, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review
US$ 28,500.00
... suppliers, by country. Product/Technology Review Comparison of leading molecular diagnostic analyzers from Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe ... in R&D. Comprehensive listings of companies developing and marketing molecular diagnostics products, by test and application. Opportunities and Strategic ...
May 2019
1398 pages
Europe Molecular Diagnostic Analyzers and Reagents, 2019-2023: A 31-Country Analysis-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing-Supplier Shares, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review
US$ 28,500.00
... technologies and products Emerging technologies Review of molecular diagnostic analyzers Specific product and business opportunities for instrument and ... in major countries. Product/Technology Review Comparison of leading molecular diagnostic analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen ...
May 2019
1170 pages
2019-2023 Competing in the France Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,850.00
This new 1125-page report from VPGMarketResearch contains 56 tables, and presents a comprehensive analysis of the French molecular diagnostics market, including: Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and ...
March 2019
1125 pages
2019-2023 Competing in the Germany Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,850.00
This new 1125-page report from VPGMarketResearch contains 56 tables, and presents a comprehensive analysis of the German molecular diagnostics market, including: Major issues pertaining to the German molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and ...
March 2019
1125 pages
2019-2023 Competing in the Italy Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,850.00
This new 1117-page report from VPGMarketResearch contains 55 tables, and presents a comprehensive analysis of the Italian molecular diagnostics market, including: Major issues pertaining to the Italian molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and ...
March 2019
1117 pages
2019-2023 Competing in the Japan Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,850.00
This new 1126-page report from VPGMarketResearch contains 56 tables, and presents a comprehensive analysis of the Japanese molecular diagnostics market, including: Major issues pertaining to the Japanese molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and ...
March 2019
1126 pages
2019-2023 Competing in the Spain Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,850.00
This new 1117-page report from VPGMarketResearch contains 55 tables, and presents a comprehensive analysis of the Spanish molecular diagnostics market, including: Major issues pertaining to the Spanish molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and ...
March 2019
1117 pages
2019-2023 Competing in the UK Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,850.00
This new 1122-page report from VPGMarketResearch contains 53 tables, and presents a comprehensive analysis of the UK molecular diagnostics market, including: Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
March 2019
1122 pages
2019-2023 Competing in the US Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 8,500.00
This new 1157-page report from VPGMarketResearch contains 65 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including: Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
March 2019
1157 pages
Global Molecular Diagnostics Market Research and Forecast, 2018-2023
US$ 3,600.00
... below mentioned segments: 1. Global Molecular Diagnostics Market Research and Analysis by Technology 2. Global Molecular Diagnostics Market Research and Analysis by Product 3. Global Molecular Diagnostics Market Research and Analysis by Application 4. Global Molecular Diagnostics Market Research and Analysis ...
January 2019
-
Global Molecular Diagnostics Market: Industry Analysis & Outlook (2018-2022)
US$ 1,000.00
... robust growth with increased research and development. The global molecular diagnostics market is expected to see innovation driven growth. With ... an in-depth analysis of the “Global Molecular Diagnostics Market”. It covers the regional and global aspect of the market. Competition is concentrated in the hands ...
January 2019
101 pages
Molecular Diagnostics: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Molecular Diagnostics in US$ Thousand by the following Applications: Infectious Disease Testing, Blood Screening, ... 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
December 2018
570 pages
2019-2023 Europe Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Market: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 19,700.00
... Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. Review ... test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...
December 2018
630 pages
